WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: ORAVANCE

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on ORAVANCE

Proof of use for ORAVANCE

We do not have any records of a proof of use for ORAVANCE at this moment.

Click here to add a proof of use for ORAVANCE

Possible trademark infringements of ORAVANCE

Basic Information about ORAVANCE

Serial Number
88338791
Filing Date
13 Mar 2019
Registration Number
7115573
Registration Date
18 Jul 2023
Mark Drawing Code
4

Classifications

Declare the trademark use of ORAVANCE on the blockchain with WikiTrademarks.io.

First use of ORAVANCE anywhere
ORAVANCE was first used on 18 Aug 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
005; 006; 018; 044; 046; 051; 052

Who owns ORAVANCE?

1. QPEX BIOPHARMA, INC. San Diego CA

2. QPEX BIOPHARMA, INC. San Diego CA

3. QPEX BIOPHARMA, INC. San Diego CA

Correspondent

Gregory B. Phillips
KNOBBE MARTENS OLSON & BEAR, LLP
2040 MAIN STREET, 14TH FLOOR
IRVINE,CA 92614

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on ORAVANCE